T. Rowe Price Associates’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
62,842
+25,252
| +67% | +$53K | ﹤0.01% | 2836 |
|
|
2025
Q1 | $65K | Buy |
37,590
+3,720
| +11% | +$6.43K | ﹤0.01% | 2893 |
|
|
2024
Q4 | $172K | Buy |
33,870
+5,801
| +21% | +$29.5K | ﹤0.01% | 2731 |
|
|
2024
Q3 | $153K | Hold |
28,069
| – | – | ﹤0.01% | 2739 |
|
|
2024
Q2 | $135K | Buy |
28,069
+12,216
| +77% | +$58.8K | ﹤0.01% | 2694 |
|
|
2024
Q1 | $50K | Buy |
15,853
+405
| +3% | +$1.28K | ﹤0.01% | 2872 |
|
|
2023
Q4 | $44K | Buy |
15,448
+1,512
| +11% | +$4.31K | ﹤0.01% | 2825 |
|
|
2023
Q3 | $41K | Buy |
13,936
+1,932
| +16% | +$5.68K | ﹤0.01% | 2793 |
|
|
2023
Q2 | $35K | Hold |
12,004
| – | – | ﹤0.01% | 2835 |
|
|
2023
Q1 | $38K | Buy |
+12,004
| New | +$38K | ﹤0.01% | 2815 |
|